| 1 |
33235193 | ADORA2A variation and adenosine A1 receptor availability in the human brain with a focus on anxiety-related brain regions: modulation by ADORA1 variation. | 2020 Nov 24 |
1 |
| 2 |
31578448 | Reconstruction of apo A2A receptor activation pathways reveal ligand-competent intermediates and state-dependent cholesterol hotspots. | 2019 Oct 2 |
1 |
| 3 |
29558203 | Enzymes of the purinergic signaling system exhibit diverse effects on the degeneration of valvular interstitial cells in a 3-D microenvironment. | 2018 Aug |
1 |
| 4 |
30044380 | Comparative Study of Carborane- and Phenyl-Modified Adenosine Derivatives as Ligands for the A2A and A3 Adenosine Receptors Based on a Rigid in Silico Docking and Radioligand Replacement Assay. | 2018 Jul 25 |
1 |
| 5 |
27915051 | Low, but not high, dose caffeine is a readily available probe for adenosine actions. | 2017 Jun |
1 |
| 6 |
27216633 | Discovery of potent adenosine A2a antagonists as potential anti-Parkinson disease agents. Non-linear QSAR analyses integrated with pharmacophore modeling. | 2016 Jul 25 |
3 |
| 7 |
25384972 | Human monocyte recognition of adenosine-based cyclic dinucleotides unveils the A2a Gαs protein-coupled receptor tonic inhibition of mitochondrially induced cell death. | 2015 Jan |
1 |
| 8 |
25770019 | Expression of CD73 and A2A receptors in cells from subjects with obesity and type 2 diabetes mellitus. | 2015 Aug |
1 |
| 9 |
24024783 | Allosteric interactions at adenosine A(1) and A(3) receptors: new insights into the role of small molecules and receptor dimerization. | 2014 Mar |
1 |
| 10 |
24595664 | The role of activated adenosine receptors in degranulation of human LAD2 mast cells. | 2014 Sep |
1 |
| 11 |
24687255 | Adenosine A2A receptor antagonists in Parkinson's disease: progress in clinical trials from the newly approved istradefylline to drugs in early development and those already discontinued. | 2014 May |
1 |
| 12 |
25393959 | Inhibition of platelet activation and thrombus formation by adenosine and inosine: studies on their relative contribution and molecular modeling. | 2014 |
5 |
| 13 |
23917951 | Non-dopaminergic treatments for motor control in Parkinson's disease. | 2013 Sep |
1 |
| 14 |
22142423 | Structure-activity relationships of truncated C2- or C8-substituted adenosine derivatives as dual acting A₂A and A₃ adenosine receptor ligands. | 2012 Jan 12 |
1 |
| 15 |
19019012 | A1 and A2a receptors mediate inhibitory effects of adenosine on the motor activity of human colon. | 2009 Apr |
1 |
| 16 |
19140664 | N-[6-amino-2-(heteroaryl)pyrimidin-4-yl]acetamides as A2A receptor antagonists with improved drug like properties and in vivo efficacy. | 2009 Feb 12 |
1 |
| 17 |
18758473 | Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. | 2008 Sep |
1 |
| 18 |
16867213 | ST 1535: a preferential A2A adenosine receptor antagonist. | 2006 Oct |
4 |
| 19 |
15294291 | Decreases in yeast expression yields of the human adenosine A2a receptor are a result of translational or post-translational events. | 2004 Sep |
1 |
| 20 |
11296702 | [Mechanisms of effects of adenosine and dopamine on modification of synapses in striato-nigral and striato-pallidal neurons]. | 2001 Feb |
1 |
| 21 |
11592813 | Influences of adenosine on the fetus and newborn. | 2001 Sep-Oct |
1 |
| 22 |
9914161 | Expression of A2B adenosine receptors in human lymphocytes: their role in T cell activation. | 1999 Feb |
1 |
| 23 |
9756374 | Purinoceptor activation of chloride transport in cystic fibrosis and CFTR-transfected pancreatic cell lines. | 1998 Aug |
1 |
| 24 |
7731018 | Tricyclic heteroaromatic systems. Synthesis and A1 and A2a adenosine binding activities of some 1-aryl-1,4-dihydro-3-methyl[1]benzopyrano[2,3-c] pyrazol-4-ones, 1-aryl-4,9-dihydro-3-methyl-1H-pyrazolo[3,4-b]quinolin-4- ones, and 1-aryl-1H-imidazo[4,5-b]quinoxalines. | 1995 Apr 14 |
2 |